nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—Amprenavir—ABCB1—colon cancer	0.00829	1	CrCbGaD
Darunavir—Lethargy—Methotrexate—colon cancer	0.0015	0.00152	CcSEcCtD
Darunavir—Cerebrovascular accident—Methotrexate—colon cancer	0.0015	0.00152	CcSEcCtD
Darunavir—Renal failure—Capecitabine—colon cancer	0.0015	0.00151	CcSEcCtD
Darunavir—Discomfort—Irinotecan—colon cancer	0.0015	0.00151	CcSEcCtD
Darunavir—Myocardial infarction—Capecitabine—colon cancer	0.00149	0.00151	CcSEcCtD
Darunavir—Neuropathy peripheral—Capecitabine—colon cancer	0.00149	0.00151	CcSEcCtD
Darunavir—Jaundice—Capecitabine—colon cancer	0.00149	0.0015	CcSEcCtD
Darunavir—Stomatitis—Capecitabine—colon cancer	0.00149	0.0015	CcSEcCtD
Darunavir—Convulsion—Fluorouracil—colon cancer	0.00148	0.00149	CcSEcCtD
Darunavir—Confusional state—Irinotecan—colon cancer	0.00147	0.00148	CcSEcCtD
Darunavir—Nervous system disorder—Vincristine—colon cancer	0.00146	0.00148	CcSEcCtD
Darunavir—Thrombocytopenia—Vincristine—colon cancer	0.00146	0.00147	CcSEcCtD
Darunavir—Haematuria—Capecitabine—colon cancer	0.00145	0.00147	CcSEcCtD
Darunavir—Chest pain—Fluorouracil—colon cancer	0.00145	0.00146	CcSEcCtD
Darunavir—Myalgia—Fluorouracil—colon cancer	0.00145	0.00146	CcSEcCtD
Darunavir—Hyperhidrosis—Vincristine—colon cancer	0.00144	0.00145	CcSEcCtD
Darunavir—Hepatobiliary disease—Capecitabine—colon cancer	0.00144	0.00145	CcSEcCtD
Darunavir—Epistaxis—Capecitabine—colon cancer	0.00144	0.00145	CcSEcCtD
Darunavir—Discomfort—Fluorouracil—colon cancer	0.00143	0.00145	CcSEcCtD
Darunavir—Shock—Irinotecan—colon cancer	0.00143	0.00144	CcSEcCtD
Darunavir—Nervous system disorder—Irinotecan—colon cancer	0.00143	0.00144	CcSEcCtD
Darunavir—Thrombocytopenia—Irinotecan—colon cancer	0.00142	0.00143	CcSEcCtD
Darunavir—Anorexia—Vincristine—colon cancer	0.00142	0.00143	CcSEcCtD
Darunavir—Irritability—Methotrexate—colon cancer	0.00141	0.00142	CcSEcCtD
Darunavir—Hyperhidrosis—Irinotecan—colon cancer	0.0014	0.00142	CcSEcCtD
Darunavir—Confusional state—Fluorouracil—colon cancer	0.0014	0.00142	CcSEcCtD
Darunavir—Mood swings—Methotrexate—colon cancer	0.0014	0.00141	CcSEcCtD
Darunavir—Bradycardia—Capecitabine—colon cancer	0.00139	0.00141	CcSEcCtD
Darunavir—Anorexia—Irinotecan—colon cancer	0.00139	0.0014	CcSEcCtD
Darunavir—Haemoglobin—Capecitabine—colon cancer	0.00138	0.00139	CcSEcCtD
Darunavir—Haemorrhage—Capecitabine—colon cancer	0.00137	0.00138	CcSEcCtD
Darunavir—Hepatitis—Capecitabine—colon cancer	0.00137	0.00138	CcSEcCtD
Darunavir—Nervous system disorder—Fluorouracil—colon cancer	0.00137	0.00138	CcSEcCtD
Darunavir—Thrombocytopenia—Fluorouracil—colon cancer	0.00136	0.00137	CcSEcCtD
Darunavir—Hypoaesthesia—Capecitabine—colon cancer	0.00136	0.00137	CcSEcCtD
Darunavir—Liver function test abnormal—Methotrexate—colon cancer	0.00136	0.00137	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Vincristine—colon cancer	0.00136	0.00137	CcSEcCtD
Darunavir—Tachycardia—Fluorouracil—colon cancer	0.00136	0.00137	CcSEcCtD
Darunavir—Urinary tract disorder—Capecitabine—colon cancer	0.00135	0.00136	CcSEcCtD
Darunavir—Insomnia—Vincristine—colon cancer	0.00135	0.00136	CcSEcCtD
Darunavir—Oedema peripheral—Capecitabine—colon cancer	0.00135	0.00136	CcSEcCtD
Darunavir—Connective tissue disorder—Capecitabine—colon cancer	0.00135	0.00136	CcSEcCtD
Darunavir—Urethral disorder—Capecitabine—colon cancer	0.00134	0.00135	CcSEcCtD
Darunavir—Paraesthesia—Vincristine—colon cancer	0.00134	0.00135	CcSEcCtD
Darunavir—Breast disorder—Methotrexate—colon cancer	0.00133	0.00134	CcSEcCtD
Darunavir—Anorexia—Fluorouracil—colon cancer	0.00133	0.00134	CcSEcCtD
Darunavir—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00133	0.00134	CcSEcCtD
Darunavir—Visual impairment—Capecitabine—colon cancer	0.00132	0.00133	CcSEcCtD
Darunavir—Insomnia—Irinotecan—colon cancer	0.00131	0.00133	CcSEcCtD
Darunavir—Paraesthesia—Irinotecan—colon cancer	0.00131	0.00132	CcSEcCtD
Darunavir—Decreased appetite—Vincristine—colon cancer	0.0013	0.00131	CcSEcCtD
Darunavir—Dyspnoea—Irinotecan—colon cancer	0.0013	0.00131	CcSEcCtD
Darunavir—Erythema multiforme—Capecitabine—colon cancer	0.00129	0.00131	CcSEcCtD
Darunavir—Somnolence—Irinotecan—colon cancer	0.00129	0.0013	CcSEcCtD
Darunavir—Gastrointestinal disorder—Vincristine—colon cancer	0.00129	0.0013	CcSEcCtD
Darunavir—Fatigue—Vincristine—colon cancer	0.00129	0.0013	CcSEcCtD
Darunavir—Eye disorder—Capecitabine—colon cancer	0.00128	0.00129	CcSEcCtD
Darunavir—Dyspepsia—Irinotecan—colon cancer	0.00128	0.00129	CcSEcCtD
Darunavir—Constipation—Vincristine—colon cancer	0.00128	0.00129	CcSEcCtD
Darunavir—Pain—Vincristine—colon cancer	0.00128	0.00129	CcSEcCtD
Darunavir—Cardiac disorder—Capecitabine—colon cancer	0.00127	0.00128	CcSEcCtD
Darunavir—Flushing—Capecitabine—colon cancer	0.00127	0.00128	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00127	0.00128	CcSEcCtD
Darunavir—Decreased appetite—Irinotecan—colon cancer	0.00126	0.00127	CcSEcCtD
Darunavir—Eosinophilia—Methotrexate—colon cancer	0.00126	0.00127	CcSEcCtD
Darunavir—Insomnia—Fluorouracil—colon cancer	0.00126	0.00127	CcSEcCtD
Darunavir—Gastrointestinal disorder—Irinotecan—colon cancer	0.00125	0.00127	CcSEcCtD
Darunavir—Fatigue—Irinotecan—colon cancer	0.00125	0.00126	CcSEcCtD
Darunavir—Paraesthesia—Fluorouracil—colon cancer	0.00125	0.00126	CcSEcCtD
Darunavir—Pancreatitis—Methotrexate—colon cancer	0.00125	0.00126	CcSEcCtD
Darunavir—Constipation—Irinotecan—colon cancer	0.00124	0.00125	CcSEcCtD
Darunavir—Pain—Irinotecan—colon cancer	0.00124	0.00125	CcSEcCtD
Darunavir—Angiopathy—Capecitabine—colon cancer	0.00124	0.00125	CcSEcCtD
Darunavir—Dyspnoea—Fluorouracil—colon cancer	0.00124	0.00125	CcSEcCtD
Darunavir—Somnolence—Fluorouracil—colon cancer	0.00124	0.00125	CcSEcCtD
Darunavir—Immune system disorder—Capecitabine—colon cancer	0.00124	0.00125	CcSEcCtD
Darunavir—Mediastinal disorder—Capecitabine—colon cancer	0.00123	0.00124	CcSEcCtD
Darunavir—Chills—Capecitabine—colon cancer	0.00123	0.00124	CcSEcCtD
Darunavir—Dyspepsia—Fluorouracil—colon cancer	0.00123	0.00124	CcSEcCtD
Darunavir—Abdominal discomfort—Methotrexate—colon cancer	0.00122	0.00123	CcSEcCtD
Darunavir—Gastrointestinal pain—Vincristine—colon cancer	0.00122	0.00123	CcSEcCtD
Darunavir—Decreased appetite—Fluorouracil—colon cancer	0.00121	0.00122	CcSEcCtD
Darunavir—Alopecia—Capecitabine—colon cancer	0.00121	0.00122	CcSEcCtD
Darunavir—Pancytopenia—Methotrexate—colon cancer	0.00121	0.00122	CcSEcCtD
Darunavir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.0012	0.00121	CcSEcCtD
Darunavir—Mental disorder—Capecitabine—colon cancer	0.0012	0.00121	CcSEcCtD
Darunavir—Feeling abnormal—Irinotecan—colon cancer	0.0012	0.00121	CcSEcCtD
Darunavir—Erythema—Capecitabine—colon cancer	0.00119	0.0012	CcSEcCtD
Darunavir—Malnutrition—Capecitabine—colon cancer	0.00119	0.0012	CcSEcCtD
Darunavir—Dysuria—Methotrexate—colon cancer	0.00119	0.0012	CcSEcCtD
Darunavir—Neutropenia—Methotrexate—colon cancer	0.00119	0.0012	CcSEcCtD
Darunavir—Pain—Fluorouracil—colon cancer	0.00119	0.0012	CcSEcCtD
Darunavir—Gastrointestinal pain—Irinotecan—colon cancer	0.00119	0.0012	CcSEcCtD
Darunavir—Abdominal pain—Vincristine—colon cancer	0.00118	0.00119	CcSEcCtD
Darunavir—Body temperature increased—Vincristine—colon cancer	0.00118	0.00119	CcSEcCtD
Darunavir—Flatulence—Capecitabine—colon cancer	0.00117	0.00118	CcSEcCtD
Darunavir—Erectile dysfunction—Methotrexate—colon cancer	0.00117	0.00118	CcSEcCtD
Darunavir—Dysgeusia—Capecitabine—colon cancer	0.00117	0.00118	CcSEcCtD
Darunavir—Abdominal pain—Irinotecan—colon cancer	0.00115	0.00116	CcSEcCtD
Darunavir—Body temperature increased—Irinotecan—colon cancer	0.00115	0.00116	CcSEcCtD
Darunavir—Feeling abnormal—Fluorouracil—colon cancer	0.00115	0.00116	CcSEcCtD
Darunavir—Muscle spasms—Capecitabine—colon cancer	0.00115	0.00116	CcSEcCtD
Darunavir—Infestation NOS—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Darunavir—Infestation—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00113	0.00114	CcSEcCtD
Darunavir—Renal failure—Methotrexate—colon cancer	0.00112	0.00113	CcSEcCtD
Darunavir—Stomatitis—Methotrexate—colon cancer	0.00111	0.00112	CcSEcCtD
Darunavir—Ill-defined disorder—Capecitabine—colon cancer	0.00111	0.00112	CcSEcCtD
Darunavir—Urticaria—Fluorouracil—colon cancer	0.00111	0.00112	CcSEcCtD
Darunavir—Anaemia—Capecitabine—colon cancer	0.0011	0.00111	CcSEcCtD
Darunavir—Body temperature increased—Fluorouracil—colon cancer	0.0011	0.00111	CcSEcCtD
Darunavir—Hypersensitivity—Vincristine—colon cancer	0.0011	0.00111	CcSEcCtD
Darunavir—Haematuria—Methotrexate—colon cancer	0.00108	0.00109	CcSEcCtD
Darunavir—Malaise—Capecitabine—colon cancer	0.00107	0.00108	CcSEcCtD
Darunavir—Hepatobiliary disease—Methotrexate—colon cancer	0.00107	0.00108	CcSEcCtD
Darunavir—Epistaxis—Methotrexate—colon cancer	0.00107	0.00108	CcSEcCtD
Darunavir—Vertigo—Capecitabine—colon cancer	0.00107	0.00108	CcSEcCtD
Darunavir—Hypersensitivity—Irinotecan—colon cancer	0.00107	0.00108	CcSEcCtD
Darunavir—Asthenia—Vincristine—colon cancer	0.00107	0.00108	CcSEcCtD
Darunavir—Syncope—Capecitabine—colon cancer	0.00107	0.00108	CcSEcCtD
Darunavir—Leukopenia—Capecitabine—colon cancer	0.00107	0.00108	CcSEcCtD
Darunavir—Palpitations—Capecitabine—colon cancer	0.00105	0.00106	CcSEcCtD
Darunavir—Loss of consciousness—Capecitabine—colon cancer	0.00105	0.00106	CcSEcCtD
Darunavir—Asthenia—Irinotecan—colon cancer	0.00104	0.00105	CcSEcCtD
Darunavir—Cough—Capecitabine—colon cancer	0.00104	0.00105	CcSEcCtD
Darunavir—Hypertension—Capecitabine—colon cancer	0.00103	0.00104	CcSEcCtD
Darunavir—Hypersensitivity—Fluorouracil—colon cancer	0.00103	0.00103	CcSEcCtD
Darunavir—Haemoglobin—Methotrexate—colon cancer	0.00102	0.00103	CcSEcCtD
Darunavir—Diarrhoea—Vincristine—colon cancer	0.00102	0.00103	CcSEcCtD
Darunavir—Haemorrhage—Methotrexate—colon cancer	0.00102	0.00103	CcSEcCtD
Darunavir—Hepatitis—Methotrexate—colon cancer	0.00102	0.00103	CcSEcCtD
Darunavir—Arthralgia—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Darunavir—Chest pain—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Darunavir—Myalgia—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Darunavir—Anxiety—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Darunavir—Urinary tract disorder—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Darunavir—Discomfort—Capecitabine—colon cancer	0.001	0.00101	CcSEcCtD
Darunavir—Urethral disorder—Methotrexate—colon cancer	0.000999	0.00101	CcSEcCtD
Darunavir—Diarrhoea—Irinotecan—colon cancer	0.000994	0.001	CcSEcCtD
Darunavir—Dry mouth—Capecitabine—colon cancer	0.000992	0.001	CcSEcCtD
Darunavir—Dizziness—Vincristine—colon cancer	0.000987	0.000995	CcSEcCtD
Darunavir—Pruritus—Fluorouracil—colon cancer	0.000985	0.000993	CcSEcCtD
Darunavir—Visual impairment—Methotrexate—colon cancer	0.000982	0.00099	CcSEcCtD
Darunavir—Confusional state—Capecitabine—colon cancer	0.000981	0.000989	CcSEcCtD
Darunavir—Erythema multiforme—Methotrexate—colon cancer	0.000964	0.000972	CcSEcCtD
Darunavir—Dizziness—Irinotecan—colon cancer	0.000961	0.000969	CcSEcCtD
Darunavir—Shock—Capecitabine—colon cancer	0.000957	0.000965	CcSEcCtD
Darunavir—Nervous system disorder—Capecitabine—colon cancer	0.000954	0.000962	CcSEcCtD
Darunavir—Eye disorder—Methotrexate—colon cancer	0.000952	0.00096	CcSEcCtD
Darunavir—Diarrhoea—Fluorouracil—colon cancer	0.000952	0.00096	CcSEcCtD
Darunavir—Thrombocytopenia—Capecitabine—colon cancer	0.000952	0.00096	CcSEcCtD
Darunavir—Tachycardia—Capecitabine—colon cancer	0.000949	0.000957	CcSEcCtD
Darunavir—Vomiting—Vincristine—colon cancer	0.000949	0.000957	CcSEcCtD
Darunavir—Cardiac disorder—Methotrexate—colon cancer	0.000946	0.000954	CcSEcCtD
Darunavir—Skin disorder—Capecitabine—colon cancer	0.000945	0.000953	CcSEcCtD
Darunavir—Rash—Vincristine—colon cancer	0.000941	0.000949	CcSEcCtD
Darunavir—Hyperhidrosis—Capecitabine—colon cancer	0.00094	0.000948	CcSEcCtD
Darunavir—Dermatitis—Vincristine—colon cancer	0.00094	0.000948	CcSEcCtD
Darunavir—Headache—Vincristine—colon cancer	0.000935	0.000943	CcSEcCtD
Darunavir—Anorexia—Capecitabine—colon cancer	0.000927	0.000935	CcSEcCtD
Darunavir—Angiopathy—Methotrexate—colon cancer	0.000925	0.000932	CcSEcCtD
Darunavir—Vomiting—Irinotecan—colon cancer	0.000924	0.000932	CcSEcCtD
Darunavir—Immune system disorder—Methotrexate—colon cancer	0.000921	0.000928	CcSEcCtD
Darunavir—Dizziness—Fluorouracil—colon cancer	0.00092	0.000928	CcSEcCtD
Darunavir—Mediastinal disorder—Methotrexate—colon cancer	0.000919	0.000926	CcSEcCtD
Darunavir—Rash—Irinotecan—colon cancer	0.000916	0.000924	CcSEcCtD
Darunavir—Dermatitis—Irinotecan—colon cancer	0.000916	0.000923	CcSEcCtD
Darunavir—Chills—Methotrexate—colon cancer	0.000914	0.000922	CcSEcCtD
Darunavir—Headache—Irinotecan—colon cancer	0.00091	0.000918	CcSEcCtD
Darunavir—Alopecia—Methotrexate—colon cancer	0.000901	0.000908	CcSEcCtD
Darunavir—Mental disorder—Methotrexate—colon cancer	0.000893	0.0009	CcSEcCtD
Darunavir—Erythema—Methotrexate—colon cancer	0.000887	0.000895	CcSEcCtD
Darunavir—Malnutrition—Methotrexate—colon cancer	0.000887	0.000895	CcSEcCtD
Darunavir—Nausea—Vincristine—colon cancer	0.000886	0.000894	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000886	0.000894	CcSEcCtD
Darunavir—Vomiting—Fluorouracil—colon cancer	0.000885	0.000892	CcSEcCtD
Darunavir—Insomnia—Capecitabine—colon cancer	0.00088	0.000887	CcSEcCtD
Darunavir—Rash—Fluorouracil—colon cancer	0.000878	0.000885	CcSEcCtD
Darunavir—Dermatitis—Fluorouracil—colon cancer	0.000877	0.000884	CcSEcCtD
Darunavir—Paraesthesia—Capecitabine—colon cancer	0.000873	0.000881	CcSEcCtD
Darunavir—Headache—Fluorouracil—colon cancer	0.000872	0.000879	CcSEcCtD
Darunavir—Dysgeusia—Methotrexate—colon cancer	0.000869	0.000876	CcSEcCtD
Darunavir—Dyspnoea—Capecitabine—colon cancer	0.000867	0.000874	CcSEcCtD
Darunavir—Nausea—Irinotecan—colon cancer	0.000863	0.00087	CcSEcCtD
Darunavir—Dyspepsia—Capecitabine—colon cancer	0.000856	0.000863	CcSEcCtD
Darunavir—Decreased appetite—Capecitabine—colon cancer	0.000846	0.000853	CcSEcCtD
Darunavir—Gastrointestinal disorder—Capecitabine—colon cancer	0.00084	0.000847	CcSEcCtD
Darunavir—Fatigue—Capecitabine—colon cancer	0.000839	0.000846	CcSEcCtD
Darunavir—Pain—Capecitabine—colon cancer	0.000832	0.000839	CcSEcCtD
Darunavir—Constipation—Capecitabine—colon cancer	0.000832	0.000839	CcSEcCtD
Darunavir—Nausea—Fluorouracil—colon cancer	0.000827	0.000834	CcSEcCtD
Darunavir—Ill-defined disorder—Methotrexate—colon cancer	0.000823	0.00083	CcSEcCtD
Darunavir—Anaemia—Methotrexate—colon cancer	0.00082	0.000827	CcSEcCtD
Darunavir—Feeling abnormal—Capecitabine—colon cancer	0.000802	0.000808	CcSEcCtD
Darunavir—Malaise—Methotrexate—colon cancer	0.0008	0.000807	CcSEcCtD
Darunavir—Vertigo—Methotrexate—colon cancer	0.000797	0.000804	CcSEcCtD
Darunavir—Gastrointestinal pain—Capecitabine—colon cancer	0.000795	0.000802	CcSEcCtD
Darunavir—Leukopenia—Methotrexate—colon cancer	0.000794	0.000801	CcSEcCtD
Darunavir—Cough—Methotrexate—colon cancer	0.000774	0.000781	CcSEcCtD
Darunavir—Urticaria—Capecitabine—colon cancer	0.000773	0.000779	CcSEcCtD
Darunavir—Abdominal pain—Capecitabine—colon cancer	0.000769	0.000775	CcSEcCtD
Darunavir—Body temperature increased—Capecitabine—colon cancer	0.000769	0.000775	CcSEcCtD
Darunavir—Convulsion—Methotrexate—colon cancer	0.000769	0.000775	CcSEcCtD
Darunavir—Arthralgia—Methotrexate—colon cancer	0.000755	0.000762	CcSEcCtD
Darunavir—Myalgia—Methotrexate—colon cancer	0.000755	0.000762	CcSEcCtD
Darunavir—Chest pain—Methotrexate—colon cancer	0.000755	0.000762	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00075	0.000756	CcSEcCtD
Darunavir—Discomfort—Methotrexate—colon cancer	0.000746	0.000753	CcSEcCtD
Darunavir—Confusional state—Methotrexate—colon cancer	0.00073	0.000736	CcSEcCtD
Darunavir—Hypersensitivity—Capecitabine—colon cancer	0.000717	0.000723	CcSEcCtD
Darunavir—Nervous system disorder—Methotrexate—colon cancer	0.00071	0.000716	CcSEcCtD
Darunavir—Thrombocytopenia—Methotrexate—colon cancer	0.000709	0.000715	CcSEcCtD
Darunavir—Skin disorder—Methotrexate—colon cancer	0.000703	0.000709	CcSEcCtD
Darunavir—Hyperhidrosis—Methotrexate—colon cancer	0.0007	0.000706	CcSEcCtD
Darunavir—Asthenia—Capecitabine—colon cancer	0.000698	0.000704	CcSEcCtD
Darunavir—Anorexia—Methotrexate—colon cancer	0.00069	0.000696	CcSEcCtD
Darunavir—Pruritus—Capecitabine—colon cancer	0.000688	0.000694	CcSEcCtD
Darunavir—Diarrhoea—Capecitabine—colon cancer	0.000666	0.000671	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00066	0.000665	CcSEcCtD
Darunavir—Insomnia—Methotrexate—colon cancer	0.000655	0.00066	CcSEcCtD
Darunavir—Paraesthesia—Methotrexate—colon cancer	0.00065	0.000656	CcSEcCtD
Darunavir—Dyspnoea—Methotrexate—colon cancer	0.000646	0.000651	CcSEcCtD
Darunavir—Somnolence—Methotrexate—colon cancer	0.000644	0.000649	CcSEcCtD
Darunavir—Dizziness—Capecitabine—colon cancer	0.000643	0.000649	CcSEcCtD
Darunavir—Dyspepsia—Methotrexate—colon cancer	0.000637	0.000643	CcSEcCtD
Darunavir—Decreased appetite—Methotrexate—colon cancer	0.000629	0.000635	CcSEcCtD
Darunavir—Gastrointestinal disorder—Methotrexate—colon cancer	0.000625	0.00063	CcSEcCtD
Darunavir—Fatigue—Methotrexate—colon cancer	0.000624	0.00063	CcSEcCtD
Darunavir—Pain—Methotrexate—colon cancer	0.000619	0.000624	CcSEcCtD
Darunavir—Vomiting—Capecitabine—colon cancer	0.000618	0.000624	CcSEcCtD
Darunavir—Rash—Capecitabine—colon cancer	0.000613	0.000618	CcSEcCtD
Darunavir—Dermatitis—Capecitabine—colon cancer	0.000613	0.000618	CcSEcCtD
Darunavir—Headache—Capecitabine—colon cancer	0.000609	0.000614	CcSEcCtD
Darunavir—Feeling abnormal—Methotrexate—colon cancer	0.000597	0.000602	CcSEcCtD
Darunavir—Gastrointestinal pain—Methotrexate—colon cancer	0.000592	0.000597	CcSEcCtD
Darunavir—Nausea—Capecitabine—colon cancer	0.000578	0.000583	CcSEcCtD
Darunavir—Urticaria—Methotrexate—colon cancer	0.000575	0.00058	CcSEcCtD
Darunavir—Abdominal pain—Methotrexate—colon cancer	0.000572	0.000577	CcSEcCtD
Darunavir—Body temperature increased—Methotrexate—colon cancer	0.000572	0.000577	CcSEcCtD
Darunavir—Hypersensitivity—Methotrexate—colon cancer	0.000533	0.000538	CcSEcCtD
Darunavir—Asthenia—Methotrexate—colon cancer	0.00052	0.000524	CcSEcCtD
Darunavir—Pruritus—Methotrexate—colon cancer	0.000512	0.000517	CcSEcCtD
Darunavir—Diarrhoea—Methotrexate—colon cancer	0.000495	0.0005	CcSEcCtD
Darunavir—Dizziness—Methotrexate—colon cancer	0.000479	0.000483	CcSEcCtD
Darunavir—Vomiting—Methotrexate—colon cancer	0.00046	0.000464	CcSEcCtD
Darunavir—Rash—Methotrexate—colon cancer	0.000457	0.00046	CcSEcCtD
Darunavir—Dermatitis—Methotrexate—colon cancer	0.000456	0.00046	CcSEcCtD
Darunavir—Headache—Methotrexate—colon cancer	0.000454	0.000457	CcSEcCtD
Darunavir—Nausea—Methotrexate—colon cancer	0.00043	0.000434	CcSEcCtD
